CELLTERMI REVIVE NX is a next-generation exosomal therapy — the world’s first 5th-generation product, acting simultaneously on all 3 key layers of the skin: epidermis, basal membrane and dermis.
The product contains 150 billion MD-exosomes per vial — the highest concentration in the world, 200 times above the market standard. Exosomes are derived from Lactobacillus paracasei, with a stabilised size < 100 nm, ensuring rapid penetration and immediate release of active components.
The unique formula combines three active complexes: CHA-Zeromelatide (for the epidermis), CHA-Nidogen-1 (for the basal membrane) and MD-Exosomes (for the dermis) — providing a complete solution for regeneration, rejuvenation, hydration, pigmentation reduction and inflammation control.
Zero immunogenicity — no allergic reactions or inflammation. No risk of rejection. No aggression to the skin.
REVIVE NX works simultaneously on three levels:
1. EPIDERMIS — CHA-ZEROMELATIDE + EGF
CHA-Zeromelatide exerts fundamental antioxidant and depigmenting action — reducing melanin content and evening out skin tone. EGF stimulates cell regeneration and the proliferation of keratinocytes, endothelial cells and fibroblasts.
2. BASAL MEMBRANE — CHA-NIDOGEN-1
Restores the dermo-epidermal junction — the connection between the epidermis and dermis. Rebuilds the skin’s barrier function and the structure of the basal membrane damaged by ageing and external factors.
3. DERMIS — MD-EXOSOMES (150 billion)
5th-generation exosomes exert deep anti-inflammatory action, restore cellular proliferation and stimulate collagen synthesis. Size < 100 nm ensures rapid penetration, immediate release and 200X more efficient delivery compared to other products.
– 150 billion MD-exosomes / vial — the highest concentration in the world
– 5th-generation exosomal therapy — the first of its kind in the world
– Action on 3 levels simultaneously: epidermis + basal membrane + dermis
– 200X more efficient delivery of active components vs. standard
– Stabilised size < 100 nm — rapid penetration and immediate release
– Zero immunogenicity — no allergies, no inflammation, no rejection risk
– Clinically proven: +25.21% hydration, +55.56% radiance, −39.56% crow's feet
– −26.82% melanin, −85.10% pigmented area (melasma) after 4 procedures
– −25.29% haemoglobin concentration, −26.22% redness after 4 procedures
– +21.12% skin texture improvement after 4 procedures
– Effective for face, neck, décolleté, hands and scalp
– Compatible with microneedling, RF, laser, peels, Air Ject, Derma Pen
– Developed in Switzerland and South Korea — pharmaceutical standards
